Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Millennium slips on lowered guidance

MLNM was off $0.62 to $13.08 on Tuesday after decreasing its

Read the full 117 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE